Anabolic steroid-induced hypogonadism (ASIH) is the functional incompetence of the testes with subnormal or impaired production of testosterone and/or spermatozoa due to administration of androgens or anabolic steroids. Anabolic-androgenic steroid (AAS), both prescription and nonprescription, use is a cause of ASIH. Current AAS use includes prescribing for wasting associated conditions. Nonpres...

INTRODUCTION Anabolic-androgenic steroid (AAS) use and testosterone therapy have been well established risk factors for the creation of a pro-thrombotic state, and to precipitate formation of thromboemboli in individuals already predisposed to thrombosis. CASE REPORT Here, we present the case of an amateur bodybuilder, with a negative thrombophilia workup, who experienced primary renal infarc...

Contrary to popular assumption, adolescent anabolic-androgenic steroid use is not limited to serious male athletes. This paper examines the relationships among gender, athletic participation, and health-related problem behaviors among adolescent steroid users. Regression analyses were performed on a nationally representative sample of over 16,000 high school students (the 1997 Youth Risk Behavi...

OBJECTIVE (1) To assess the personality profiles of the anabolic androgenic steroid users (AAS) and (2) to determine whether valid premorbid personality traits could be obtained from cross sectional assessment using multisource data. METHODS The first author became a participant-observer in a group of body builders. An experimental group of body builders who had been using AAS for no more tha...

OBJECTIVE To examine levels of C reactive protein in users of anabolic androgenic steroids (AAS) compared with age matched control groups consisting of AAS using (but abstinent)/resistance trained and non-drug using/sedentary controls. METHOD Subjects included AAS using bodybuilders (n = 10); bodybuilders who denied AAS use (n = 10); sedentary controls (n = 8). Venous blood was sampled, from ...